Evobright moved into its new headquarter in close proximity to Vienna Biocenter

The newly founded Biotech-Startup Evobright has moved into its headquarter, close to the beating heart of Vienna’s Biomedical Research scene.

By locating its headquarters at Dock 27 in Vienna, very close to the Vienna Biocenter and Vienna Startup Labs, Evobright underlines its commitment to building a thriving Austrian biotech industry. Evobright’s CEO, Dr. Klaus-Peter Künkele, summarizes the advantages of the location as follows: “The strong infrastructure, the networking opportunities with other Austrian biotech companies and CROs, and the pin-point public support for the most promising startups provide an excellent basis for the commercial success of our company.” Dr. Christoph Baumann, COO of Evobright, added, “We share the building with other biotechs such as Myllia Biotechnology, which facilitates cooperation and concrete collaboration on our projects. Several CROs and CMOs such as NBS-C in Vienna and Polymun in Korneuburg are also located nearby, which may become potential partners in the preclinical development of our molecules.”